InvestorsHub Logo

DewDiligence

04/05/22 9:13 PM

#241942 RE: dealerschool2006 #241939

…it takes you a whole year to respond to my question that i really would have liked to know back then…

I didn’t interpret your post from 2021 (#msg-160736938) to be an actual question. If I had, I probably would’ve examined the phase-2a data release more thoroughly to try to figure out the rationale for the selloff that day.

semi_infinite

04/06/22 12:44 PM

#241953 RE: dealerschool2006 #241939

IMRA - the odds of failure for early bioscience stories has always been high and there are now even more "pre" preclinical publicly traded via SPACs and PIPEs.